This finding may be related to stronger immune reactions of women with an already immunogenic “hot” MSI-H tumor and an additional boosting effect of CTx (Klein et al. 2016, Rivera Vargas et al. 2017, Bruni et al. 2020; Kohlruss et al. 2021). Here, CYP27A1 is linked to neoplasm.